MedTrace Logo

Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure

NCT02730702 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2018-08-01

No results posted yet for this study

Summary

This is a study whose focus is on understanding the clinical utility of rectal ultrastructure in detecting colonic neoplasm. The method uses Low-coherence Enhanced Backscattering Spectroscopy (LEBS).

Conditions

Interventions

DEVICE

LEBS - Low coherence enhanced backscattering

Unprepped patients will have the LEBS probe brought into contact with the rectal mucosa, upon which 10 random readings will be obtained.

Sponsors & Collaborators

  • American BioOptics, LLC

    lead INDUSTRY

Principal Investigators

  • The Quyen Nguyen, Ph.D. · American BioOptics

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02730702 on ClinicalTrials.gov